statepi home
Homepage MACS Homepage WIHS Homepage CKID Homepage
Liver Cancer

Biomarkers Homepage
Oltipraz Homepage

                      Liver Cancer, HBV and Aflatoxin

This study, started in 1993, is composed of 3 projects on molecular biomarkers for environmental carcinogens.

The Oltipraz Chemoprevention Trial is a Phase II randomized clinical trial designed to evaluate weekly and daily administrations of oltipraz for reducing urinary and/or serum aflatoxin biomarkers compared to placebo.

Funding provided by the National Institute of Environmental Health Sciences
and the National Cancer Institute.

This page was last updated October 2001.